Solesta approved by FDA as fecal incontinence treatment

SILVER SPRING, Md. — The Food and Drug Administration has approved an injectable gel for fecal incontinence, the agency said.

The FDA announced the approval of Oceana Therapeutics’ Solesta for patients who have involuntarily lost bowel control and for whom such therapies as diet change, fiber therapy and antimotility medications have failed.

Fecal incontinence affects more than 5.5 million Americans, according to the National Institutes of Health.